South Africa’s Department of Health says HIV antiretroviral (ARV) medicine supply will remain secure after a Pretoria High Court judgment overturns two disputed tender awards related to ARV procurement. The department states that patients will continue receiving treatment despite the court’s order to reallocate the tender awards.
Both outlets reference the court decision and its implications for medicine continuity, focusing on what the ruling means for patients. The Citizen frames the story around reassurance from the health department, emphasising that the medicine supply is “safe” following the court action. IOL likewise highlights the department’s position that the overturned tender arrangement will not disrupt ARV availability, centring the expectation of uninterrupted treatment while the tender outcomes are adjusted. Overall, the coverage aligns on the key point that the court challenges to tender awards occur alongside assurances of ongoing ARV supply.
